Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Carter

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Genes, Brain, and Behavior|September 25, 2014
A genetic interaction network model of a complex neurological diseaseA L Tyler, T C McGarr, B J Beyer, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analoguesK H Kim, Y C Martin, D W Brooks, et al.
Journal of Medicinal Chemistry|July 1, 1991
Identification and synthesis of a receptor binding site of human anaphylatoxin C5aM Kawai, D A Quincy, B Lane, et al.
Journal of Medicinal Chemistry|January 1, 1980
Glycerides as prodrugs. 2. 1,3-Dialkanoyl-2-(2-methyl-4-oxo-1,3-benzodioxan-2-yl)glycerides (cyclic aspirin triglycerides) as antiinflammatory agentsG Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|January 1, 1980
Glycerides as prodrugs. 3. Synthesis and antiinflammatory activity of [1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl]glycerides (indomethacin glycerides)G Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|June 1, 1979
Glycerides as prodrugs. 1. Synthesis and antiinflammatory activity of 1,3-bis(alkanoyl)-2-(O-acetylsalicyloyl)glycerides (aspirin triglycerides)G Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|January 24, 1992
Improvements in the minimum binding sequence of C5a: examination of His-67Y S Or, R F Clark, B Lane, et al.
FEBS Letters|January 25, 1993
Structure-activity profiles of macrolactam immunosuppressant FK-506 analoguesM Kawai, B C Lane, G C Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coliW Mandecki, K W Mollison, T J Bolling, et al.
European Journal of Pharmacology|November 7, 1996
Pharmacological modulation of eosinophil influx into the lungs of Brown Norway ratsM T Namovic, R E Walsh, C Goodfellow, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Genes, Brain, and Behavior|September 25, 2014
A genetic interaction network model of a complex neurological diseaseA L Tyler, T C McGarr, B J Beyer, et al.
Journal of Pharmaceutical Sciences|March 1, 1994
Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analoguesK H Kim, Y C Martin, D W Brooks, et al.
Journal of Medicinal Chemistry|July 1, 1991
Identification and synthesis of a receptor binding site of human anaphylatoxin C5aM Kawai, D A Quincy, B Lane, et al.
Journal of Medicinal Chemistry|January 1, 1980
Glycerides as prodrugs. 2. 1,3-Dialkanoyl-2-(2-methyl-4-oxo-1,3-benzodioxan-2-yl)glycerides (cyclic aspirin triglycerides) as antiinflammatory agentsG Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|January 1, 1980
Glycerides as prodrugs. 3. Synthesis and antiinflammatory activity of [1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetyl]glycerides (indomethacin glycerides)G Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|June 1, 1979
Glycerides as prodrugs. 1. Synthesis and antiinflammatory activity of 1,3-bis(alkanoyl)-2-(O-acetylsalicyloyl)glycerides (aspirin triglycerides)G Y Paris, D L Garmaise, D G Cimon, et al.
Journal of Medicinal Chemistry|January 24, 1992
Improvements in the minimum binding sequence of C5a: examination of His-67Y S Or, R F Clark, B Lane, et al.
FEBS Letters|January 25, 1993
Structure-activity profiles of macrolactam immunosuppressant FK-506 analoguesM Kawai, B C Lane, G C Hsieh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coliW Mandecki, K W Mollison, T J Bolling, et al.
European Journal of Pharmacology|November 7, 1996
Pharmacological modulation of eosinophil influx into the lungs of Brown Norway ratsM T Namovic, R E Walsh, C Goodfellow, et al.
Pageof 8